In vivo class switch of B cells after cord blood stem cell transplantation in severe combined immune deficient (SCID) patient [1]

American Journal of Hematology

Volumn 65, Issue 2, 2000, Pages 176-177

  Nagasawa, Masayuki ^a   Imai, Masako ^a   Imai, Kohsuke ^a   Itoh, Sukeyuki ^a   Kajiwara, Michiko ^a   Morio, Tomohiro ^a   Nonoyama, Shigeaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ACTIVATION; CASE REPORT; COMBINED IMMUNODEFICIENCY; DISEASE SEVERITY; GENE SWITCHING; HUMAN; IN VIVO STUDY; INFANT; LETTER; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD;

ANTIGENS, CD40; B-LYMPHOCYTES; CELL TRANSPLANTATION; FETAL BLOOD; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN ISOTYPES; INFANT; MALE; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 0033832764     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200010)65:2<176::AID-AJH16>3.0.CO;2-O     Document Type: Letter

References (6)

1. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
2. Outcomes among 562 recipients of placental-blood transplants from unrelated donors
3. Kinetics of T-cell development of umbilical cord blood transplantation in severe immunodeficiency disorders
4. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand
5. The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation
6. The CD40 ligand, gp39, is defective in activated T-cells from patients with X-linked hyper-IgM syndrome